Company
| Legal Name | Daiichi Sankyo Europe GmbH |
| Headquarters | Pfaffenhofen An Der Ilm, Germany |
| Website | https://daiichisankyo.com |
Daiichi Sankyo, Inc. is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for hypertension, pain management, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma.. To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.
| Country | City | Job Ads |
|---|---|---|
| Germany | Pfaffenhofen An Der Ilm | 1535 |
| Germany | München | 370 |
| United States | Mesa | 192 |
| Germany | Pfaffenhofen An Der Ilm Bei München | 119 |
| Germany | Munich | 70 |
| Switzerland | Zürich | 54 |
| Germany | Bavaria | 46 |
| United States | Pfaffenhofen A.d. Ilm | 43 |
| United States | Munich | 34 |
| Spain | Madrid | 25 |
Loading map...
Legal Form: GmbH
Company Type: Public
Company Size: 1001 - 5000
Revenue: > 10 billion (USD)
Job Ads found: 2600
Job Ads per Month: 54.2
Hiring Locations: 21
| Date of first job ad | 10.09.2019, 22:00 |
| Date of last job ad | 17.06.2026, 10:30 |
| Date merged | 18.06.2026, 09:23 |
| Date created | 10.09.2019, 22:00 |